Jiangsu Sihuan Bioengineering Co., Ltd (SHE:000518)

China flag China · Delayed Price · Currency is CNY
2.880
+0.080 (2.86%)
Mar 10, 2026, 3:04 PM CST
33.33%
Market Cap 2.88B
Revenue (ttm) 341.90M
Net Income (ttm) -108.07M
Shares Out 1.03B
EPS (ttm) -0.10
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 20,265,530
Average Volume 11,197,532
Open 2.810
Previous Close 2.800
Day's Range 2.790 - 2.910
52-Week Range 1.720 - 2.880
Beta 0.38
RSI 62.89
Earnings Date Apr 18, 2026

About SHE:000518

Jiangsu Sihuan Bioengineering Co., Ltd. engages in the pharmaceutical business in China. It offers delusheng and xindelusheng, an anti-tumor biotherapeutic drug for the treatment of kidney cancer, malignant melanoma, and cancerous chest and abdominal mass. It also engages in breeding and sales of flowers and seedlings; and landscaping projects. Jiangsu Sihuan Bioengineering Co., Ltd. was founded in 1992 and is headquartered in Jiangyin, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1992
Employees 277
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 000518
Full Company Profile

Financial Performance

In 2024, SHE:000518's revenue was 203.52 million, a decrease of -13.55% compared to the previous year's 235.42 million. Losses were -109.99 million, 46.1% more than in 2023.

Financial Statements

News

There is no news available yet.